PMV Pharmaceuticals, Inc.
PMVP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001699382
No open-market purchases or sales by PMV Pharmaceuticals, Inc. insiders were filed in the last 90 days; 64 institutions reported holding it in 13F filings for Q2 2026, worth $45.9M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding PMV Pharmaceuticals, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 106 | 104 | −2 |
| Shares | 51.8M | 54.2M | +2.48M (+4.8%) |
| Value | $324.0M | $333.0M | +$9.02M (+2.8%) |
New holders (8)
Institutions that held PMV Pharmaceuticals, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Schonfeld Strategic Advisors LLC | 71,295 | $437.8K | 0.00% |
| Trexquant Investment LP | 68,202 | $418.8K | 0.01% |
| Marshall Wace, LLP | 58,062 | $356.5K | 0.00% |
| Jane Street Group, LLC | 39,034 | $239.7K | 0.00% |
| ExodusPoint Capital Management, LP | 38,238 | $235.0K | 0.00% |
| PEAK6 Investments LLC | 32,500 | $199.6K | 0.01% |
| Algert Global LLC | 27,790 | $170.6K | 0.01% |
| GWM Advisors LLC | 31 | $190 | 0.00% |
Sold out (10)
Institutions that held PMV Pharmaceuticals, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Bank of Montreal | 698,184 | $4.44M |
| Sphera Funds Management Ltd. | 187,800 | $1.18M |
| HRT Financial LP | 48,323 | $302.0K |
| UBS Asset Management Americas Inc | 62,355 | $297.4K |
| Man Group plc | 41,800 | $261.7K |
| Prudential Financial Inc | 33,360 | $208.8K |
| XTX Topco Ltd | 27,225 | $170.4K |
| Squarepoint Ops LLC | 19,041 | $119.2K |
| Walleye Capital LLC | 11,471 | $71.8K |
| Russell Investments Group, Ltd. | 1,592 | $9.96K |